Back to Journals » Therapeutics and Clinical Risk Management » Volume 13
Review
Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
26,402 | Dovepress* | 14,839+ | 1,988 | 16,827 | |
PubMed Central* | 11,563 | 1,354 | 12,917 | ||
Totals | 26,402 | 3,342 | 29,744 | ||
*Since 14 July 2017 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
16 | 1 | 0 | 0 | 4 | 11 |
View citations on PubMed Central and Google Scholar